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• SARS-CoV-2 RNA can be readily detected in feces and occasionally urine
• Severe GI dysfunction only occurs in a small number of cases (11 ± 2%)
• Likelihood of SARS-Co V-2 being transmitted via feces appears very low
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Figure 1. Summary of symptoms experienced in clinically reported SARS-Co V-2 infections. 
The data is the summary of 48 independent reports involving a total of 3 706 patients. The 
yellow bars are those associated with gastrointestinal problems. In the box plots, the 
boundary of the box closest to zero indicates the 25th percentile, a black line within the box 
marks the median, and the boundary of the box farthest from zero indicates the 75th 
percentile. Whiskers above and below the box indicate the 10th and 90th percentiles. Points 
above and below the whiskers indicate outliers outside the 10th and 90th percentiles. The 
average size of the cohort studies was 79 ± 21 (n = 48). 





